Last updated on February 2018

Evaluation of Medical Practice in the Management of Bone Metastases After Injectable Bone Antiresorptive Treatment and Its Influence on Quality of Life


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Tumor With Bone Metastasis
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patient with histologically proven tumor with bone metastasis, single or multiple (with or without metastasis extra-osseous)
  • Patients treated with injectable bone antiresorptive therapy for 12 months or more
  • Signed written informed consent

Exclusion Criteria:

  • patient with any medical or psychiatric condition or disease which would make the patient inappropriate to complete quality of life questionaries
  • patient under guardianship, curator or under the protection of justice, pregnant or breast-feeding women

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.